ACE2 and diabetic kidney disease: Additionally, angiotensin-converting enzyme 2 (ACE2)/Ang(1-7) axis exhibits protection on DKD treatment in animal studies (Chou et al., 2013; Liu et al., 2020a), indicating a promising therapeutic target against DKD.